Developing a new medicine is a complex process. Researchers must understand a disease, identify a biological target, find or design a suitable molecule, test it in laboratories, assess its safety, and evaluate it through clinical trials. Many drug candidates fail because they are ineffective, unsafe, unstable, difficult to manufacture, or…

Financial Framework Measuring the ROI of AI Automation: A Leader’s Guide to Real Business Impact How to connect AI initiatives to verifiable financial metrics, operational improvements, and risk-adjusted business value. Artificial intelligence can automate repetitive work, support faster decisions, reduce errors, and improve customer interactions. However, these benefits do not…

Artificial intelligence is changing how companies make decisions, serve customers, manage operations, and compete. Yet adopting AI does not automatically create business value. Many organisations invest in tools or pilot projects without clearly defining the problem they need to solve. The result is often a disconnected solution that employees do…